Track Intelligent Bio Solutions Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Intelligent Bio Solutions Inc. Common Stock INBS Open Intelligent Bio Solutions Inc. Common Stock in new tab

3.65 USD
EPS
-14.45
P/B
0.27
ROE
-150.20
Beta
4.24
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 14, 2026
EPS-14.45
Book Value8.96
Price to Book0.27
Debt/Equity17.67
% Insiders3.926%
Growth
Revenue Growth0.48%
Estimates
Forward P/E6.91
Forward EPS0.35

DCF Valuation

Tweak assumptions to recompute fair value for Intelligent Bio Solutions Inc. Common Stock (INBS)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Intelligent Bio Solutions Inc. Common Stock Logo Intelligent Bio Solutions Inc. Common Stock Analysis (INBS)

United States Health Care Official Website Stock

Is Intelligent Bio Solutions Inc. Common Stock a good investment? Intelligent Bio Solutions Inc. Common Stock (INBS) is currently trading at 3.65 USD.

Earnings Schedule: Intelligent Bio Solutions Inc. Common Stock is expected to release its next earnings report on Aug. 14, 2026. The market consensus estimate for Forward EPS is 0.35.

Investor FAQ

Does Intelligent Bio Solutions Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Intelligent Bio Solutions Inc. Common Stock?

Intelligent Bio Solutions Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 14, 2026. The company currently has a trailing EPS of -14.45.

Company Profile

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Exchange Ticker
NMS (United States) INBS

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Feb. 10, 2023 0.050000
Jan. 29, 2024 0.080000
Dec. 16, 2025 0.100000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion